Iron bisglycinate chelate

Description

Ferrous iron is reacted with glycine to form bis-glycinate chelate, a non-electrically charged compound that is totally nutritionally functional. The absence of electrical charge, uncommon for an iron supplement, makes it less likely that Iron Glycinate™ can interfere with absorption of other minerals such as calcium, vitamin E or vitamin C. Iron solubility from iron bis-glycine chelate is not affected by pH changes from 2-6. This means it travels unchanged through the stomach, into the intestine, where it is absorbed and released for transport throughout the body.*
Patient compliance with iron bis-glycinate appears to be better than that seen with inorganic forms of iron supplements for two reasons. First, the taste: In a study with 145 pregnant women (that concluded daily supplementation with iron bis-glycinate chelate was significantly more effective even at a lower dose than ferrous sulfate) the percentage of taste complaints among the women given ferrous sulfate was 29.8%, while 0% of the women on the bis-glycinate chelate complained about taste. Second, iron bis-glycinate is less likely to have any of the gastrointestinal side-effects associated with standard iron supplementation.*
A published absorption study showed there was a significant correlation between iron absorption of iron bis-glycinate chelate to serum ferritin (r = -0.60, p < 0.03) (The higher the ferritin the lower the absorption and vice versa.) The amount of iron stored in the body regulates iron bis-glycinate chelate absorption. This translates into less chance of toxicity. Another benefit of the bis-glycinate chelate form of iron over other iron supplements is that it doesn’t act as a pro-oxidant.*
Iron is an important component of hemoglobin, myoglobin, and ferritin. These proteins are involved in the transport, storage, and release of oxygen to the tissues.*

References
1. Pineda O, Ashmead HD. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition. 2001 May;17(5):381-4. [PMID:11377130]
2. Szarfarc SC, de Cassana LM, Fujimori E, Guerra-Shinohara EM, de Oliveira IM. Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women. Arch Latinoam Nutr. 2001 Mar;51(1 Suppl 1):42-7 [PMID: 1688081]
3. Iron, PDR: http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/iro_0149.shtml [accessed 11.11.05]
4. Plummer-Vinson Syndrome. http://www.emedicine.com/med/topic3431.htm [Accessed 11.11.05]
5. Hilal Mocan, Alisan Yildiran, Fazil Orhan, Erol Erduran. Breath holding spells in 91 children and response to treatment with iron Arch Dis Child 1999;81:261-262 ( September ) [http://adc.bmjjournals.com/cgi/content/full/81/3/261] Accessed 11.11.05
6. Brolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LB, Kenler HA, Cody RP. Prophylactic iron supplementation after RouxenY gastric bypass: a prospective, double blind, randomized study. Arch Surg. 1998 Jul;133 (7): 740-4. [PMID 9688002]
7. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003 Nov;121(5):985-8 [PMID:14708596]
8. Hershko C, Ronson A, Souroujon M, Maschler Z, Heyd J, Patz J. Variable hematological presentation of autoimmune gastritis:age-related progression from iron deficiency to cobalamin depletion. Blood. 2005 Oct 20; [Epub ahead of print] [PMID:16239424]
9. Ashmead SD. The chemistry of ferrous bis-glycinate chelate. Arch Latinoam Nutr. 2001 Mar; 51(1 Suppl 1):7-12 [PMID: 11688084]
10.Garcia-Casal MN, Layrisse M. The effect of change in pH on the solubility of iron bis-glycinate chelate and other iron compounds. Arch Latinoam Nutr. 2001 Mar;51(1 Suppl 1):35-6. [PMID: 11688079]
11.Szarfarc SC, de Cassana LM, Fujimori E, Guerra-Shinohara EM, de Oliveira IM. Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women. Arch Latinoam Nutr. 2001 Mar;51(1 Suppl 1):42-7 [PMID: 11688081]
12.Olivares M, Pizarro F. Bioavailability of iron bis-glycinate chelate in water. Arch Latinoam Nutr. 2001 Mar;51 (1 Suppl 1): 22-5 [PMID: 11688077]
13.Pineda O, Ashmead HD. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition. 2001 May;17(5):381-4. [PMID: 11377130]
14.Patterson AJ, Brown WJ, Roberts DC. Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. J Am Coll Nutr. 2001 Aug;20(4):337-42
15.Pelton R, Lavalle JB, Hawkins EB, et al. Drug Induced Nutrient Depletion Handbook. 2nd ed . Cincinnati, OH: Lexi-Comp Inc; 2001